U.S. High Content Screening Market to Reach USD 1.22 Billion and Europe USD 0.97 Billion by 2035, Supported by AI-Powered ...

Induced pluripotent stem cells (iPSCs) have transformed research in regenerative medicine, disease modelling, drug discovery, and personalised medicine. But anyone who has worked with iPSCs knows the ...

As an embryo develops from a small cluster of stem cells, those once "blank slate" cells begin to take on more specialized ...

This article is based on a poster originally authored by D. Cole and N. Bevan. 3D models, including spheroids and organoids, are increasingly used to investigate disease and development. Developing, ...

Creative Biolabs, a premier provider of 3D biology and preclinical research solutions, today announced the expansion of its specialized primary immune cell catalog.

Regulators are steering drug testing away from animals, and the systems stepping in each capture only a slice of a living body.

SYDNEY--(BUSINESS WIRE)--Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology ...

Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced the launch of STORganoid ™, an ...